BDNF and Parkinson disease: Gouteng, the most crucial component in YGS, demonstrates remarkable neuroprotective effects by modulating IL-1β and brain-derived neurotrophic factor (BDNF), as well as the PI3K/Akt/mTOR signaling pathway, in experimental models of drug-induced PD [17, 18].